Results 291 to 300 of about 249,317 (377)
Amyloid beta protein affects poly(ADP-ribose) polymerase activity in PC-12 cells in culture
Robert Banasik
openalex +2 more sources
Abstract Aims Two general phenotypes of heart failure (HF) are recognized: HF with reduced ejection fraction (HFrEF) and with preserved EF (HFpEF). To develop phenotype‐specific approaches to treatment, distinguishing biomarkers are needed. The goal of this study was to utilize quantitative metabolomics on a large, diverse population to replicate and ...
Fawaz Naeem+13 more
wiley +1 more source
Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics-Part A: Endogenous Compounds and Repurposed Drugs. [PDF]
Atanasova M.
europepmc +1 more source
Systematic approach to dilated cardiomyopathy diagnosis. Dilated cardiomyopathy is a clinical diagnosis characterized by the presence of left ventricular dilatation and systolic disfunction unexplained by abnormal loading conditions or coronary artery disease.
Kristian Galanti+14 more
wiley +1 more source
Misfolded amyloid-beta conformational variants (strains) as drivers of Alzheimer's disease neuropathology. [PDF]
Saieva S, Morales R.
europepmc +1 more source
Role of a tyrosine residue in metal-induced aggregation of the amyloid beta-peptide
T. Miura+2 more
openalex +2 more sources
Microglia degrade Alzheimer's amyloid-beta deposits extracellularly via digestive exophagy. [PDF]
Jacquet RG+8 more
europepmc +1 more source
Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosis
Aims Disease‐related changes in body composition are associated with worse outcomes in chronic heart failure. In cardiac amyloidosis (CA), the prognostic value of direct body composition measures is understudied. Methods and results We identified 160 consecutive patients with CA (transthyretin [ATTR] or light chain [AL]) diagnosed between 2001 and 2021
Joshua Longinow+4 more
wiley +1 more source